Logo image of AVPT

AVEPOINT INC (AVPT) Stock Fundamental Analysis

NASDAQ:AVPT - Nasdaq - US0536041041 - Common Stock - Currency: USD

17.83  -0.37 (-2.03%)

After market: 18.18 +0.35 (+1.96%)

Fundamental Rating

6

Taking everything into account, AVPT scores 6 out of 10 in our fundamental rating. AVPT was compared to 282 industry peers in the Software industry. AVPT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. AVPT is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AVPT was profitable.
AVPT had a positive operating cash flow in the past year.
In the past 5 years AVPT always reported negative net income.
AVPT had a positive operating cash flow in 4 of the past 5 years.
AVPT Yearly Net Income VS EBIT VS OCF VS FCFAVPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

AVPT has a Return On Assets of -4.00%. This is comparable to the rest of the industry: AVPT outperforms 51.77% of its industry peers.
AVPT has a Return On Equity (-6.66%) which is comparable to the rest of the industry.
AVPT has a better Return On Invested Capital (2.76%) than 71.28% of its industry peers.
Industry RankSector Rank
ROA -4%
ROE -6.66%
ROIC 2.76%
ROA(3y)-6.84%
ROA(5y)-13.69%
ROE(3y)-13.09%
ROE(5y)-73.41%
ROIC(3y)N/A
ROIC(5y)N/A
AVPT Yearly ROA, ROE, ROICAVPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

AVPT has a Operating Margin of 3.91%. This is in the better half of the industry: AVPT outperforms 69.50% of its industry peers.
AVPT has a better Gross Margin (75.36%) than 67.38% of its industry peers.
In the last couple of years the Gross Margin of AVPT has grown nicely.
Industry RankSector Rank
OM 3.91%
PM (TTM) N/A
GM 75.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.79%
AVPT Yearly Profit, Operating, Gross MarginsAVPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AVPT is destroying value.
The number of shares outstanding for AVPT has been increased compared to 1 year ago.
AVPT has more shares outstanding than it did 5 years ago.
AVPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AVPT Yearly Shares OutstandingAVPT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
AVPT Yearly Total Debt VS Total AssetsAVPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 9.01 indicates that AVPT is not in any danger for bankruptcy at the moment.
AVPT's Altman-Z score of 9.01 is amongst the best of the industry. AVPT outperforms 81.56% of its industry peers.
There is no outstanding debt for AVPT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.01
ROIC/WACC0.25
WACC10.94%
AVPT Yearly LT Debt VS Equity VS FCFAVPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 2.15 indicates that AVPT has no problem at all paying its short term obligations.
AVPT's Current ratio of 2.15 is fine compared to the rest of the industry. AVPT outperforms 65.25% of its industry peers.
AVPT has a Quick Ratio of 2.15. This indicates that AVPT is financially healthy and has no problem in meeting its short term obligations.
AVPT's Quick ratio of 2.15 is fine compared to the rest of the industry. AVPT outperforms 65.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 2.15
AVPT Yearly Current Assets VS Current LiabilitesAVPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

AVPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.36%.
The Revenue has grown by 21.70% in the past year. This is a very strong growth!
The Revenue has been growing by 23.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)21.7%
Revenue growth 3Y19.86%
Revenue growth 5Y23.27%
Sales Q2Q%24.86%

3.2 Future

Based on estimates for the next years, AVPT will show a very strong growth in Earnings Per Share. The EPS will grow by 110.93% on average per year.
The Revenue is expected to grow by 23.07% on average over the next years. This is a very strong growth
EPS Next Y440.6%
EPS Next 2Y162.72%
EPS Next 3Y110.93%
EPS Next 5YN/A
Revenue Next Year21.89%
Revenue Next 2Y19.88%
Revenue Next 3Y20.62%
Revenue Next 5Y23.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AVPT Yearly Revenue VS EstimatesAVPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
AVPT Yearly EPS VS EstimatesAVPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 254.71, the valuation of AVPT can be described as expensive.
AVPT's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of AVPT to the average of the S&P500 Index (27.30), we can say AVPT is valued expensively.
With a Price/Forward Earnings ratio of 51.67, AVPT can be considered very expensive at the moment.
AVPT's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.76. AVPT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 254.71
Fwd PE 51.67
AVPT Price Earnings VS Forward Price EarningsAVPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AVPT.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AVPT indicates a somewhat cheap valuation: AVPT is cheaper than 62.77% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 46.71
EV/EBITDA 169.93
AVPT Per share dataAVPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AVPT's earnings are expected to grow with 110.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y162.72%
EPS Next 3Y110.93%

0

5. Dividend

5.1 Amount

No dividends for AVPT!.
Industry RankSector Rank
Dividend Yield N/A

AVEPOINT INC

NASDAQ:AVPT (7/11/2025, 8:00:02 PM)

After market: 18.18 +0.35 (+1.96%)

17.83

-0.37 (-2.03%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners62.82%
Inst Owner Change0%
Ins Owners34.06%
Ins Owner Change-5.49%
Market Cap3.62B
Analysts80
Price Target20.69 (16.04%)
Short Float %3.56%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-85.69%
Min EPS beat(2)-180.31%
Max EPS beat(2)8.93%
EPS beat(4)2
Avg EPS beat(4)-73.12%
Min EPS beat(4)-180.31%
Max EPS beat(4)18.43%
EPS beat(8)5
Avg EPS beat(8)-31.36%
EPS beat(12)8
Avg EPS beat(12)-45.2%
EPS beat(16)9
Avg EPS beat(16)-588.81%
Revenue beat(2)1
Avg Revenue beat(2)1.11%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)2.91%
Revenue beat(4)3
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-0.69%
Max Revenue beat(4)4.41%
Revenue beat(8)7
Avg Revenue beat(8)2.22%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)11
Avg Revenue beat(16)0.58%
PT rev (1m)0%
PT rev (3m)6.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)23.2%
EPS NY rev (1m)1.15%
EPS NY rev (3m)5.16%
Revenue NQ rev (1m)0.67%
Revenue NQ rev (3m)4.45%
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)4.22%
Valuation
Industry RankSector Rank
PE 254.71
Fwd PE 51.67
P/S 10.38
P/FCF 46.71
P/OCF 44.39
P/B 10.08
P/tB 11.64
EV/EBITDA 169.93
EPS(TTM)0.07
EY0.39%
EPS(NY)0.35
Fwd EY1.94%
FCF(TTM)0.38
FCFY2.14%
OCF(TTM)0.4
OCFY2.25%
SpS1.72
BVpS1.77
TBVpS1.53
PEG (NY)0.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4%
ROE -6.66%
ROCE 3.5%
ROIC 2.76%
ROICexc 27.77%
ROICexgc N/A
OM 3.91%
PM (TTM) N/A
GM 75.36%
FCFM 22.23%
ROA(3y)-6.84%
ROA(5y)-13.69%
ROE(3y)-13.09%
ROE(5y)-73.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.79%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 72.45%
Cap/Sales 1.16%
Interest Coverage 250
Cash Conversion 424.02%
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 2.15
Altman-Z 9.01
F-Score5
WACC10.94%
ROIC/WACC0.25
Cap/Depr(3y)70.47%
Cap/Depr(5y)101.2%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y440.6%
EPS Next 2Y162.72%
EPS Next 3Y110.93%
EPS Next 5YN/A
Revenue 1Y (TTM)21.7%
Revenue growth 3Y19.86%
Revenue growth 5Y23.27%
Sales Q2Q%24.86%
Revenue Next Year21.89%
Revenue Next 2Y19.88%
Revenue Next 3Y20.62%
Revenue Next 5Y23.07%
EBIT growth 1Y240.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.86%
EBIT Next 3Y35.86%
EBIT Next 5YN/A
FCF growth 1Y2122.84%
FCF growth 3Y222.06%
FCF growth 5YN/A
OCF growth 1Y1136.86%
OCF growth 3Y160.48%
OCF growth 5YN/A